TWD 744.0
(-0.67%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 2.15 Billion TWD | 10.75% |
2022 | 1.94 Billion TWD | 113.09% |
2021 | 913.62 Million TWD | -15.87% |
2020 | 1.08 Billion TWD | 265.52% |
2019 | 297.11 Million TWD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 2.38 Billion TWD | 10.46% |
2024 Q2 | 4.98 Billion TWD | 109.27% |
2023 Q4 | 2.15 Billion TWD | -6.84% |
2023 Q2 | 1.98 Billion TWD | 10.39% |
2023 Q1 | 1.79 Billion TWD | -9.86% |
2023 FY | 2.15 Billion TWD | 10.75% |
2023 Q3 | 2.31 Billion TWD | 16.81% |
2022 Q3 | 2.36 Billion TWD | 0.0% |
2022 Q4 | 1.99 Billion TWD | -15.86% |
Name | Inventory | Inventory Difference |
---|---|---|
Grape King Bio Ltd | 737.18 Million TWD | -192.482% |
Standard Chem & Pharm CO., LTD. | 1.61 Billion TWD | -33.509% |
Maywufa Company Ltd. | 257.91 Million TWD | -735.999% |
ScinoPharm Taiwan, Ltd. | 1.51 Billion TWD | -42.645% |
Lotus Pharmaceutical Co., Ltd. | 3.77 Billion TWD | 42.89% |
LIWANLI Innovation Co., Ltd. | 60.81 Million TWD | -3445.165% |
YungShin Global Holding Corporation | 2.77 Billion TWD | 22.246% |
PhytoHealth Corporation | 163.09 Million TWD | -1222.052% |
SCI Pharmtech, Inc. | 529.53 Million TWD | -307.177% |
Formosa Laboratories, Inc. | 1.59 Billion TWD | -34.972% |
PharmaEssentia Corporation | 1.45 Billion TWD | -47.818% |